{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PAI-1", "berberine", "hepatocellular carcinoma", "invasion", "migration", "uPA"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27092498", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "06"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "04", "Day": "16"}], "ELocationID": ["577", "10.3390/ijms17040577"], "Language": ["eng"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "17", "Issue": "4", "PubDate": {"Year": "2016", "Month": "Apr", "Day": "16"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine.", "Pagination": {"StartPage": "577", "MedlinePgn": "577"}, "Abstract": {"AbstractText": ["Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death and its prognosis remains poor due to the high risk of tumor recurrence and metastasis. Berberine (BBR) is a natural compound derived from some medicinal plants, and accumulating evidence has shown its potent anti-tumor activity with diverse action on tumor cells, including inducing cancer cell death and blocking cell cycle and migration. Molecular targets of berberine involved in its inhibitory effect on the invasiveness remains not yet clear. In this study, we identified that berberine exhibits a potent inhibition on the invasion and migration of HCC cells. This was accompanied by a dose-dependent down-regulation of expression of Cyclooxygenase-2 (COX-2), nuclear factor kappa B (NF-\u03baB), urokinase-type plasminogen activator (uPA) and matrix metalloproteinase (MMP)-9 in berberine-treated HCC cells. Furthermore, berberine inactivated p38 and Erk1/2 signaling pathway in HCC cells. Primarily, this may be attributed to the up-regulation of plasminogen activator inhibitor-1 (PAI-1), a tumor suppressor that can antagonize uPA receptor and down-regulation of uPA. Blockade of uPA receptor-associated pathways leads to reduced invasiveness and motility of berberine-treated HCC cells. In conclusion, our findings identified for the first time that inactivation of uPA receptor by up-regulation of PAI-1 and down-regulation of uPA is involved in the inhibitory effect of berberine on HCC cell invasion and migration."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei University of Medicine, 39 Chaoyang Mid-Road, Shiyan 442000, China. wangxb@hbmu.edu.cn."}, {"Identifier": [], "Affiliation": "Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, 30 South Renmin Road, Shiyan 442000, China. wangxb@hbmu.edu.cn."}], "LastName": "Wang", "ForeName": "Xuanbin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China. ckwang@hku.hk."}], "LastName": "Wang", "ForeName": "Ning", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei University of Medicine, 39 Chaoyang Mid-Road, Shiyan 442000, China. hongliangli@hbmu.edu.cn."}, {"Identifier": [], "Affiliation": "Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, 30 South Renmin Road, Shiyan 442000, China. hongliangli@hbmu.edu.cn."}], "LastName": "Li", "ForeName": "Hongliang", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei University of Medicine, 39 Chaoyang Mid-Road, Shiyan 442000, China. liuming@hbmu.edu.cn."}, {"Identifier": [], "Affiliation": "Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, 30 South Renmin Road, Shiyan 442000, China. liuming@hbmu.edu.cn."}], "LastName": "Liu", "ForeName": "Ming", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei University of Medicine, 39 Chaoyang Mid-Road, Shiyan 442000, China. fengjuncao@hbmu.edu.cn."}], "LastName": "Cao", "ForeName": "Fengjun", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei University of Medicine, 39 Chaoyang Mid-Road, Shiyan 442000, China. xjyu@hbmu.edu.cn."}], "LastName": "Yu", "ForeName": "Xianjun", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei University of Medicine, 39 Chaoyang Mid-Road, Shiyan 442000, China. zhangjx@hbmu.edu.cn."}], "LastName": "Zhang", "ForeName": "Jingxuan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei University of Medicine, 39 Chaoyang Mid-Road, Shiyan 442000, China. tanyan@hbmu.edu.cn."}], "LastName": "Tan", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chinese Herbal Pharmacology, Oncology Center, Renmin Hospital, Hubei University of Medicine, 39 Chaoyang Mid-Road, Shiyan 442000, China. longchaoxiang@hbmu.edu.cn."}, {"Identifier": [], "Affiliation": "Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, 30 South Renmin Road, Shiyan 442000, China. longchaoxiang@hbmu.edu.cn."}], "LastName": "Xiang", "ForeName": "Longchao", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China. yfeng@hku.hk."}], "LastName": "Feng", "ForeName": "Yibin", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plasminogen Activator Inhibitor 1"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "EC 3.4.21.73", "NameOfSubstance": "Urokinase-Type Plasminogen Activator"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": ["drug therapy", "immunology", "pathology"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Down-Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "immunology", "pathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug effects", "immunology", "pathology"], "DescriptorName": "Liver"}, {"QualifierName": ["drug therapy", "immunology", "pathology"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": ["pathology", "prevention & control"], "DescriptorName": "Neoplasm Invasiveness"}, {"QualifierName": ["analysis", "immunology"], "DescriptorName": "Plasminogen Activator Inhibitor 1"}, {"QualifierName": ["drug effects"], "DescriptorName": "Up-Regulation"}, {"QualifierName": ["analysis", "immunology"], "DescriptorName": "Urokinase-Type Plasminogen Activator"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics, 2012. CA: Cancer J. Clin. 2015;65:87\u2013108. doi: 10.3322/caac.21262.", "ArticleIdList": ["10.3322/caac.21262", "25651787"]}, {"Citation": "Chen J.G., Zhang S.W. Liver cancer epidemic in China: Past, present and future. Semin. Cancer Biol. 2011;21:59\u201369. doi: 10.1016/j.semcancer.2010.11.002.", "ArticleIdList": ["10.1016/j.semcancer.2010.11.002", "21144900"]}, {"Citation": "Wang X., Wang N., Cheung F., Lao L., Li C., Feng Y. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: Current progress on pharmacological actions and mechanisms. J. Integr. Med. 2015;13:142\u2013164. doi: 10.1016/S2095-4964(15)60171-6.", "ArticleIdList": ["10.1016/S2095-4964(15)60171-6", "26006028"]}, {"Citation": "Tang J., Feng Y., Tsao S., Wang N., Curtain R., Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J. Ethnopharmacol. 2009;126:5\u201317. doi: 10.1016/j.jep.2009.08.009.", "ArticleIdList": ["10.1016/j.jep.2009.08.009", "19686830"]}, {"Citation": "Wang N., Zhu M., Wang X., Tan H.Y., Tsao S.W., Feng Y. Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma. Biochim. Biophys. Acta. 2014;1839:849\u2013857. doi: 10.1016/j.bbagrm.2014.05.027.", "ArticleIdList": ["10.1016/j.bbagrm.2014.05.027", "24942805"]}, {"Citation": "Hou Q., Tang X., Liu H., Tang J., Yang Y., Jing X., Xiao Q., Wang W., Gou X., Wang Z. Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147. Cancer Sci. 2011;102:1287\u20131292. doi: 10.1111/j.1349-7006.2011.01933.x.", "ArticleIdList": ["10.1111/j.1349-7006.2011.01933.x", "21443647"]}, {"Citation": "Hur J., Hyun M., Lim S., Lee W., Kim D. The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J. Cell. Biochem. 2009;107:955\u2013964. doi: 10.1002/jcb.22198.", "ArticleIdList": ["10.1002/jcb.22198", "19492307"]}, {"Citation": "Yip N.K., Ho W.S. Berberine induces apoptosis via the mitochondrial pathway in liver cancer cells. Oncol. Rep. 2013;30:1107\u20131112.", "ArticleIdList": ["23784371"]}, {"Citation": "Yang X., Huang N. Berberine induces selective apoptosis through the AMPK-mediated mitochondrial/caspase pathway in hepatocellular carcinoma. Mol. Med. Rep. 2013;8:505\u2013510.", "ArticleIdList": ["23732865"]}, {"Citation": "Lopes Barreto D., Struijk D.G., Krediet R.T. Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis. Am. J. Kidney Dis. 2015;65:748\u2013753. doi: 10.1053/j.ajkd.2014.10.022.", "ArticleIdList": ["10.1053/j.ajkd.2014.10.022", "25530106"]}, {"Citation": "Yu R., Zhang Z.Q., Wang B., Jiang H.X., Cheng L., Shen L.M. Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation. Cancer Cell Int. 2014;14 doi: 10.1186/1475-2867-14-49.", "ArticleIdList": ["10.1186/1475-2867-14-49", "PMC4079188", "24991192"]}, {"Citation": "Tan Y.L., Goh D., Ong E.S. Investigation of differentially expressed proteins due to the inhibitory effects of berberine in human liver cancer cell line HepG2. Mol. Biosyst. 2006;2:250\u2013258. doi: 10.1039/b517116d.", "ArticleIdList": ["10.1039/b517116d", "16880943"]}, {"Citation": "Wang L., Wei D., Han X., Zhang W., Fan C., Zhang J., Mo C., Yang M., Li J., Wang Z., et al. The combinational effect of vincristine and berberine on growth inhibition and apoptosis induction in hepatoma cells. J. Cell. Biochem. 2014;115:721\u2013730. doi: 10.1002/jcb.24715.", "ArticleIdList": ["10.1002/jcb.24715", "24243568"]}, {"Citation": "Guo N., Yan A., Gao X., Chen Y., He X., Hu Z., Mi M., Tang X., Gou X. Berberine sensitizes rapamycin-mediated human hepatoma cell death in vitro. Mol. Med. Rep. 2014;10:3132\u20133138. doi: 10.3892/mmr.2014.2608.", "ArticleIdList": ["10.3892/mmr.2014.2608", "25310356"]}, {"Citation": "Wang X.N., Han X., Xu L.N., Yin L.H., Xu Y.W., Qi Y., Peng J.Y. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine. 2008;15:1062\u20131068. doi: 10.1016/j.phymed.2008.05.002.", "ArticleIdList": ["10.1016/j.phymed.2008.05.002", "18579357"]}, {"Citation": "Jie S., Li H., Tian Y., Guo D., Zhu J., Gao S., Jiang L. Berberine inhibits angiogenic potential of HepG2 cell line through VEGF down-regulation in vitro. J. Gastroenterol. Hepatol. 2011;26:179\u2013185. doi: 10.1111/j.1440-1746.2010.06389.x.", "ArticleIdList": ["10.1111/j.1440-1746.2010.06389.x", "21175812"]}, {"Citation": "Wang N., Feng Y., Lau E.P.W., Tsang C., Ching Y., Man K., Tong Y., Nagamatsu T., Su W., Tsao S. F-actin reorganization and inactivation of Rho signaling pathway involved in the inhibitory effect of Coptidis rhizoma on hepatoma cell migration. Integr. Cancer Ther. 2010;9 doi: 10.1177/1534735410379121.", "ArticleIdList": ["10.1177/1534735410379121", "21106616"]}, {"Citation": "Tsang C.M., Lau E.P.W., Di K., Cheung P.Y., Hau P.M., Ching Y.P., Wong Y.C., Cheung A.L.M., Wan T.S.K., Tong Y., et al. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int. J. Mol. Med. 2009;24:131\u2013138.", "ArticleIdList": ["19513545"]}, {"Citation": "Tsang C.M., Cheung K.C., Cheung Y.C., Man K., Lui V.W., Tsao S.W., Feng Y. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma. Biochim. Biophys. Acta. 2015;1852:541\u2013551. doi: 10.1016/j.bbadis.2014.12.004.", "ArticleIdList": ["10.1016/j.bbadis.2014.12.004", "25496992"]}, {"Citation": "Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u2013899. doi: 10.1016/j.cell.2010.01.025.", "ArticleIdList": ["10.1016/j.cell.2010.01.025", "PMC2866629", "20303878"]}, {"Citation": "Binder B.R., Mihaly J., Prager G.W. uPAR\u2013uPA\u2013PAI-1 interactions and signaling: A vascular biologist\u2019s view. Thromb. Haemost. 2007;97:336\u2013342. doi: 10.1160/TH06-11-0669.", "ArticleIdList": ["10.1160/TH06-11-0669", "17334498"]}, {"Citation": "McMahon B.J., Kwaan H.C. Components of the plasminogen-plasmin system as biologic markers for cancer. Adv. Exp. Med. Biol. 2015;867:145\u2013156.", "ArticleIdList": ["26530365"]}, {"Citation": "Wang N., Feng Y., Cheung F., Chow O.Y., Wang X., Su W., Tong Y. A comparative study on the hepatoprotective action of bear bile and Coptidis rhizoma aqueous extract on experimental liver fibrosis in rats. BMC Complement. Altern. Med. 2012;12:239. doi: 10.1186/1472-6882-12-239.", "ArticleIdList": ["10.1186/1472-6882-12-239", "PMC3543725", "23190573"]}, {"Citation": "Feng Y., Siu K.Y., Ye X., Wang N., Yuen M.F., Leung C.H., Tong Y., Kobayashi S. Hepatoprotective effects of berberine on carbon tetrachloride-induced acute hepatotoxicity in rats. Chin. Med. 2010;5:33. doi: 10.1186/1749-8546-5-33.", "ArticleIdList": ["10.1186/1749-8546-5-33", "PMC2949732", "20849653"]}, {"Citation": "Leta\u0161iov\u00e1 S., Jantov\u00e1 S., \u010cip\u00e1k L., M\u00fa\u010dkov\u00e1 M. Berberine\u2014Antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett. 2006;239:254\u2013262. doi: 10.1016/j.canlet.2005.08.024.", "ArticleIdList": ["10.1016/j.canlet.2005.08.024", "16229943"]}, {"Citation": "Wang L., Liu L., Shi Y., Cao H., Chaturvedi R., Calcutt M.W., Hu T., Ren X., Wilson K.T., Polk D.B., et al. Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor. PLoS ONE. 2012;7:577. doi: 10.1371/journal.pone.0036418.", "ArticleIdList": ["10.1371/journal.pone.0036418", "PMC3344856", "22574158"]}, {"Citation": "Ho Y.-T., Lu C.-C., Yang J.-S., Chiang J.-H., Li T.-C., Ip S.-W., Hsia T.-C., Liao C.-L., Lin J.-G., Wood W.G., et al. Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res. 2009;29:4063\u20134070.", "ArticleIdList": ["19846952"]}, {"Citation": "Patil J., Kim J., Jayaprakasha G. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur. J. Pharmacol. 2010;645:70\u201378. doi: 10.1016/j.ejphar.2010.07.037.", "ArticleIdList": ["10.1016/j.ejphar.2010.07.037", "20691179"]}, {"Citation": "Hsu W., Hsieh Y., Kuo H., Teng C., Huang H., Wang C., Yang S., Liou Y., Kuo W. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch. Toxicol. 2007;81:719\u2013728. doi: 10.1007/s00204-006-0169-y.", "ArticleIdList": ["10.1007/s00204-006-0169-y", "17673978"]}, {"Citation": "Lin J.P., Yang J.S., Lee J.H., Hsieh W.T., Chung J.G. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J. Gastroenterol. 2006;12:21\u201328. doi: 10.3748/wjg.v12.i1.21.", "ArticleIdList": ["10.3748/wjg.v12.i1.21", "PMC4077487", "16440412"]}, {"Citation": "Kim J.S., Oh D., Yim M.J., Park J.J., Kang K.R., Cho I.A., Moon S.M., Oh J.S., You J.S., Kim C.S., et al. Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells. Oncol. Rep. 2015;33:1775\u20131782. doi: 10.3892/or.2015.3768.", "ArticleIdList": ["10.3892/or.2015.3768", "PMC4440222", "25634589"]}, {"Citation": "Wang X., Feng Y., Wang N., Cheung F., Tan H.Y., Zhong S., Li C., Kobayashi S. Chinese medicines induce cell death: The molecular and cellular mechanisms for cancer therapy. BioMed. Res. Int. 2014;2014 doi: 10.1155/2014/530342.", "ArticleIdList": ["10.1155/2014/530342", "PMC4212527", "25379508"]}, {"Citation": "To C., Liew C., Wang X., Wang N., Feng Y. Comparison of components and anti-liver cancer activity in vitro between Huanglian and Yunlian. J. Bioequivalence Bioavailab. 2012;4:86\u201390."}, {"Citation": "Van Doren S.R. Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol. 2015;44\u201346:224\u2013231. doi: 10.1016/j.matbio.2015.01.005.", "ArticleIdList": ["10.1016/j.matbio.2015.01.005", "PMC4466143", "25599938"]}, {"Citation": "Nascimento Dda C., Durigan Rde C., Tibana R.A., Durigan J.L., Navalta J.W., Prestes J. The response of matrix metalloproteinase-9 and -2 to exercise. Sports Med. 2015;45:269\u2013278. doi: 10.1007/s40279-014-0265-8.", "ArticleIdList": ["10.1007/s40279-014-0265-8", "25252612"]}, {"Citation": "Lin C.W., Chou Y.E., Chiou H.L., Chen M.K., Yang W.E., Hsieh M.J., Yang S.F. Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression. Expert Opin. Ther. Targets. 2014;18:1109\u20131120. doi: 10.1517/14728222.2014.947962.", "ArticleIdList": ["10.1517/14728222.2014.947962", "25109417"]}, {"Citation": "Singh T., Vaid M., Katiyar N., Sharma S., Katiyar S.K. Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2 and prostaglandin E2 receptors. Carcinogenesis. 2011;32:86\u201392. doi: 10.1093/carcin/bgq215.", "ArticleIdList": ["10.1093/carcin/bgq215", "PMC3924040", "20974686"]}, {"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646\u2013674. doi: 10.1016/j.cell.2011.02.013.", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Brown G.T., Murray G.I. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 2015;237:273\u2013281. doi: 10.1002/path.4586.", "ArticleIdList": ["10.1002/path.4586", "26174849"]}, {"Citation": "Wu C.M., Li T.M., Tan T.W., Fong Y.C., Tang C.H. Berberine reduces the metastasis of chondrosarcoma by modulating the \u03b1v\u03b2 3 integrin and the pkc\u03b4, c-Src, and AP-1 signaling pathways. Evid. Based Complement. Alternat. Med. 2013;2013:423164. doi: 10.1155/2013/423164.", "ArticleIdList": ["10.1155/2013/423164", "PMC3763569", "24027594"]}, {"Citation": "Fu L., Chen W., Guo W., Wang J., Tian Y., Shi D., Zhang X., Qiu H., Xiao X., Kang T., et al. Berberine targets AP-2/hTERT, NF-\u03baB/COX-2, HIF-1\u03b1/VEGF and cytochrome-c/caspase signaling to suppress human cancer cell growth. PLoS ONE. 2013;8:577. doi: 10.1371/journal.pone.0069240.", "ArticleIdList": ["10.1371/journal.pone.0069240", "PMC3711861", "23869238"]}, {"Citation": "Liu X., Ji Q., Ye N., Sui H., Zhou L., Zhu H., Fan Z., Cai J., Li Q. Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway. PLoS ONE. 2015;10:577. doi: 10.1371/journal.pone.0123478.", "ArticleIdList": ["10.1371/journal.pone.0123478", "PMC4425560", "25954974"]}, {"Citation": "Dhillon A.S., Hagan S., Rath O., Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279\u20133290. doi: 10.1038/sj.onc.1210421.", "ArticleIdList": ["10.1038/sj.onc.1210421", "17496922"]}, {"Citation": "Kozlova N., Jensen J.K., Chi T.F., Samoylenko A., Kietzmann T. PAI-1 modulates cell migration in a LRP1-dependent manner via \u03b2-catenin and Erk1/2. Thromb. Haemost. 2015;113:988\u2013998. doi: 10.1160/TH14-08-0678.", "ArticleIdList": ["10.1160/TH14-08-0678", "25694133"]}, {"Citation": "Lee Y.R., Kim K.M., Jeon B.H., Choi S. The hexane fraction of naematoloma sublateritium extract suppresses the TNF-\u03b1-induced metastatic potential of MDA-MB-231 breast cancer cells through modulation of the JNK and p38 pathways. Int. J. Oncol. 2014;45:1284\u20131292. doi: 10.3892/ijo.2014.2526.", "ArticleIdList": ["10.3892/ijo.2014.2526", "24968898"]}, {"Citation": "Wang X., Xiang L., Li H., Chen P., Feng Y., Zhang J., Yang N., Li F., Wang Y., Zhang Q., et al. The role of HMGB1 signaling pathway in the development and progression of hepatocellular carcinoma: A review. Int. J. Mol. Sci. 2015;16:22527\u201322540. doi: 10.3390/ijms160922527.", "ArticleIdList": ["10.3390/ijms160922527", "PMC4613322", "26393575"]}, {"Citation": "Montuori N., Cosimato V., Rinaldi L., Rea V.E., Alfano D., Ragno P. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors. Thromb. Haemost. 2013;109:309\u2013318. doi: 10.1160/TH12-08-0546.", "ArticleIdList": ["10.1160/TH12-08-0546", "23238745"]}, {"Citation": "Nho K.J., Chun J.M., Lee A.Y., Kim H.K. Anti-metastatic effects of Rheum Palmatum L. extract in human MDA-MB-231 breast cancer cells. Environ. Toxicol. Pharmacol. 2015;40:30\u201338. doi: 10.1016/j.etap.2015.05.006.", "ArticleIdList": ["10.1016/j.etap.2015.05.006", "26056975"]}, {"Citation": "Roy A., Coum A., Marinescu V.D., Polajeva J., Smits A., Nelander S., Uhrbom L., Westermark B., Forsberg-Nilsson K., Ponten F., et al. Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells. Oncotarget. 2015;6:23647\u201323661. doi: 10.18632/oncotarget.4640.", "ArticleIdList": ["10.18632/oncotarget.4640", "PMC4695142", "26164207"]}, {"Citation": "Chen H., Peng H., Liu W., Sun Y., Su N., Tang W., Zhang X., Wang J., Cui L., Hu P., et al. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis. Surgery. 2015;158:1704\u20131713. doi: 10.1016/j.surg.2015.04.053.", "ArticleIdList": ["10.1016/j.surg.2015.04.053", "26275833"]}, {"Citation": "Peng P.L., Hsieh Y.S., Wang C.J., Hsu J.L., Chou F.P. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol. Appl. Pharmacol. 2006;214:8\u201315. doi: 10.1016/j.taap.2005.11.010.", "ArticleIdList": ["10.1016/j.taap.2005.11.010", "16387334"]}, {"Citation": "Akudugu J., Serafin A., Bohm L. Further evaluation of uPA and PAI-1 as biomarkers for prostatic diseases. J. Cancer Res. Clin. Oncol. 2015;141:627\u2013631. doi: 10.1007/s00432-014-1848-3.", "ArticleIdList": ["10.1007/s00432-014-1848-3", "25323935"]}, {"Citation": "Diebold I., Kraicun D., Bonello S., Gorlach A. The \u2018PAI-1 paradox\u2019 in vascular remodeling. Thromb. Haemost. 2008;100:984\u2013991.", "ArticleIdList": ["19132221"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "1", "Day": "12"}, {"Year": "2016", "Month": "4", "Day": "2"}, {"Year": "2016", "Month": "4", "Day": "8"}, {"Year": "2016", "Month": "4", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["27092498", "PMC4849033", "10.3390/ijms17040577", "ijms17040577"]}}], "PubmedBookArticle": []}